このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

脳卒中後の非侵襲的電気脊髄刺激による手と腕の運動回復 (HARNESS)

2026年10月30日 更新者:Chet Moritz、University of Washington

The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.

Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.

The aims of the study are:

  1. to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
  2. to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.

調査の概要

研究の種類

介入

入学 (推定)

6

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Fatma Inanici
  • 電話番号:206-787-2692
  • メール:finanici@uw.edu

研究場所

    • Washington
      • Seattle、Washington、アメリカ、98105
        • 募集
        • University of Washington
        • 副調査官:
          • Fatma Inanici, MD, PhD
        • 主任研究者:
          • Chet T Moritz, PhD
        • コンタクト:
          • Fatma Inanici, MD, Ph.D.
          • 電話番号:2067872692
          • メール:finanici@uw.edu

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

21年~80年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
  • At least six months post-stroke
  • Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
  • Medically and neurologically stable, as determined by medical history and documented physical examination
  • For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
  • Ability to attend sessions three times per week
  • Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
  • Ability to read, comprehend and speak English

Exclusion Criteria:

  • Hemorrhagic stroke
  • History of multiple strokes
  • Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
  • Aphasia or any other deficit in communication that interferes with reasonable study participation
  • Moderate to severe cognitive impairment
  • Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
  • Severe spasticity in the upper limb
  • Taking baclofen more than 30 mg/day
  • Change in baclofen dose within four weeks before enrollment
  • Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
  • Botulinum toxin injection to the upper limb muscles within six months before enrollment
  • Severe joint contractures in the affected hand and arm
  • History of spontaneous seizure that had occurred one month or longer after the stroke

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Activity Based Rehabilitation

Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

実験的:Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation

Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

Electrical stimulation of the spinal cord using surface electrodes

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline - Fugl-Meyer assessment of the upper limb
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Pinch and grip force
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Measurement of hand strengths using a dynamometry.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Modified Ashworth Scale
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Wolf Motor Function Test
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

二次結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline - Action Research Arm Test
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Box and Blocks Test
時間枠:"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Revised Nottingham Sensory Assessment
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Stroke Impact Scale
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Short Form-36
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Patients Global Impression of Change
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - H-reflex test
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Somatosensory evoked potentials test
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of sensory pathways between the brain and the limb.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Spinally evoked motor potentials test
時間枠:"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Chet Moritz, PhD、University of Washington

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2022年10月1日

一次修了 (推定)

2027年12月31日

研究の完了 (推定)

2027年12月31日

試験登録日

最初に提出

2022年10月13日

QC基準を満たした最初の提出物

2022年10月18日

最初の投稿 (実際)

2022年10月24日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月4日

QC基準を満たした最後の更新が送信されました

2026年10月30日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

はい

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する